Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 186

1.

Castration resistance in prostate cancer is mediated by the kinase NEK6.

Choudhury AD, Schinzel AC, Cotter MB, Lis RT, Labella K, Lock YJ, Izzo F, Guney I, Bowden M, Li YY, Patel J, Hartman E, Carr SA, Schenone M, Jaffe JD, Kantoff PW, Hammerman PS, Hahn WC.

Cancer Res. 2016 Nov 29. pii: canres.0455.2016. [Epub ahead of print]

PMID:
27899381
2.

Multidetector computer tomography in the pancreatic adenocarcinoma assessment: an update.

Granata V, Fusco R, Catalano O, Setola SV, de Lutio di Castelguidone E, Piccirillo M, Palaia R, Grassi R, Granata F, Izzo F, Petrillo A.

Infect Agent Cancer. 2016 Nov 15;11:57. Review.

3.

HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2.

De Re V, De Zorzi M, Caggiari L, Lauletta G, Tornesello ML, Fognani E, Miorin M, Racanelli V, Quartuccio L, Gragnani L, Russi S, Pavone F, Ghersetti M, Costa EG, Casarin P, Bomben R, Mazzaro C, Basaglia G, Berretta M, Vaccher E, Izzo F, Buonaguro FM, De Vita S, Zignego AL, De Paoli P, Dolcetti R.

Oncotarget. 2016 Jun 21;7(25):37487-37497. doi: 10.18632/oncotarget.9303.

4.

Intravoxel incoherent motion (IVIM) in diffusion-weighted imaging (DWI) for Hepatocellular carcinoma: correlation with histologic grade.

Granata V, Fusco R, Catalano O, Guarino B, Granata F, Tatangelo F, Avallone A, Piccirillo M, Palaia R, Izzo F, Petrillo A.

Oncotarget. 2016 Oct 15. doi: 10.18632/oncotarget.12689. [Epub ahead of print]

5.

Radiological assessment of anal cancer: an overview and update.

Granata V, Fusco R, Reginelli A, Roberto L, Granata F, Rega D, Rotondo A, Grassi R, Izzo F, Petrillo A.

Infect Agent Cancer. 2016 Oct 12;11:52. Review.

6.

Immediate Adverse Reactions to Gadolinium-Based MR Contrast Media: A Retrospective Analysis on 10,608 Examinations.

Granata V, Cascella M, Fusco R, dell'Aprovitola N, Catalano O, Filice S, Schiavone V, Izzo F, Cuomo A, Petrillo A.

Biomed Res Int. 2016;2016:3918292. doi: 10.1155/2016/3918292.

7.

Radio-frequency ablation-based studies on VX2rabbit models for HCC treatment.

Bimonte S, Leongito M, Piccirillo M, de Angelis C, Pivonello C, Granata V, Izzo F.

Infect Agent Cancer. 2016 Aug 12;11:38. doi: 10.1186/s13027-016-0082-9. Review.

8.

Rheology-sensitive response of zeolite-supported anti-inflammatory drug systems.

Pasquino R, Di Domenico M, Izzo F, Gaudino D, Vanzanella V, Grizzuti N, de Gennaro B.

Colloids Surf B Biointerfaces. 2016 Oct 1;146:938-44. doi: 10.1016/j.colsurfb.2016.07.039.

PMID:
27479877
9.

Curcumin AntiCancer Studies in Pancreatic Cancer.

Bimonte S, Barbieri A, Leongito M, Piccirillo M, Giudice A, Pivonello C, de Angelis C, Granata V, Palaia R, Izzo F.

Nutrients. 2016 Jul 16;8(7). pii: E433. doi: 10.3390/nu8070433. Review.

10.

Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma.

Pezzuto F, Izzo F, Buonaguro L, Annunziata C, Tatangelo F, Botti G, Buonaguro FM, Tornesello ML.

Oncotarget. 2016 Jun 2. doi: 10.18632/oncotarget.9801. [Epub ahead of print]

11.

MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.

Venturutti L, Cordo Russo RI, Rivas MA, Mercogliano MF, Izzo F, Oakley RH, Pereyra MG, De Martino M, Proietti CJ, Yankilevich P, Roa JC, Guzmán P, Cortese E, Allemand DH, Huang TH, Charreau EH, Cidlowski JA, Schillaci R, Elizalde PV.

Oncogene. 2016 Dec 1;35(48):6189-6202. doi: 10.1038/onc.2016.151.

PMID:
27157613
12.

Genetic and epigenetic determinants of B-cell lymphoma evolution.

Izzo F, Landau DA.

Curr Opin Hematol. 2016 Jul;23(4):392-401. doi: 10.1097/MOH.0000000000000258.

PMID:
27135978
13.

The Therapeutic Targets of miRNA in Hepatic Cancer Stem Cells.

Bimonte S, Leongito M, Barbieri A, Del Vecchio V, Falco M, Giudice A, Palaia R, Albino V, Di Giacomo R, Petrillo A, Granata V, Izzo F.

Stem Cells Int. 2016;2016:1065230. doi: 10.1155/2016/1065230. Review.

14.

Electrochemotherapy in pancreatic adenocarcinoma treatment: pre-clinical and clinical studies.

Bimonte S, Leongito M, Granata V, Barbieri A, Del Vecchio V, Falco M, Nasto A, Albino V, Piccirillo M, Palaia R, Amore A, Giacomo Rd, Lastoria S, Setola SV, Fusco R, Petrillo A, Izzo F.

Radiol Oncol. 2016 Feb 16;50(1):14-20. doi: 10.1515/raon-2016-0003. Review.

15.

Genetic characterization of Italian field strains of Schmallenberg virus based on N and NSs genes.

Izzo F, Cosseddu GM, Polci A, Iapaolo F, Pinoni C, Capobianco Dondona A, Valleriani F, Monaco F.

Virus Genes. 2016 Aug;52(4):582-5. doi: 10.1007/s11262-016-1335-9.

PMID:
27059241
16.

The Role of miRNAs in the Regulation of Pancreatic Cancer Stem Cells.

Bimonte S, Barbieri A, Leongito M, Palma G, Del Vecchio V, Falco M, Palaia R, Albino V, Piccirillo M, Amore A, Petrillo A, Granata V, Izzo F.

Stem Cells Int. 2016;2016:8352684. doi: 10.1155/2016/8352684. Review.

17.

Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.

Tornesello ML, Buonaguro L, Izzo F, Buonaguro FM.

Oncotarget. 2016 May 3;7(18):25087-102. doi: 10.18632/oncotarget.7837.

18.

CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.

Circelli L, Sciammarella C, Guadagno E, Tafuto S, del Basso de Caro M, Botti G, Pezzullo L, Aria M, Ramundo V, Tatangelo F, Losito NS, Ieranò C, D'Alterio C, Izzo F, Ciliberto G, Colao A, Faggiano A, Scala S.

Oncotarget. 2016 Apr 5;7(14):18865-75. doi: 10.18632/oncotarget.7738.

19.

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).

Avallone A, Piccirillo MC, Aloj L, Nasti G, Delrio P, Izzo F, Di Gennaro E, Tatangelo F, Granata V, Cavalcanti E, Maiolino P, Bianco F, Aprea P, De Bellis M, Pecori B, Rosati G, Carlomagno C, Bertolini A, Gallo C, Romano C, Leone A, Caracò C, de Lutio di Castelguidone E, Daniele G, Catalano O, Botti G, Petrillo A, Romano GM, Iaffaioli VR, Lastoria S, Perrone F, Budillon A.

BMC Cancer. 2016 Feb 8;16:69. doi: 10.1186/s12885-016-2102-y.

20.

The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.

Pivonello C, Negri M, De Martino MC, Napolitano M, de Angelis C, Provvisiero DP, Cuomo G, Auriemma RS, Simeoli C, Izzo F, Colao A, Hofland LJ, Pivonello R.

Oncotarget. 2016 Mar 1;7(9):9718-31. doi: 10.18632/oncotarget.6836.

Items per page

Supplemental Content

Loading ...
Support Center